Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Brii Biosciences Provides Latest Clinical Development and Corporate Updates 2023-07-06 07:19
Sirnaomics Establishes a Strategic Partnership with EDIRNA Inc., an RNA-Editing Therapeutic Company 2023-07-05 23:07
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development 2023-07-05 22:05
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China 2023-07-05 20:00
BGI CEO Yin Ye Advocates for Global Technology Sharing 2023-07-05 14:17
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China 2023-07-04 21:16
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer 2023-07-04 20:55
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy 2023-07-04 20:42
PETCUBES INTRODUCES GROUNDBREAKING 'VETERINARY SUPPORT DIET' RANGE FOR DOGS WITH SPECIAL HEALTH NEEDS 2023-07-04 14:00
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES 2023-07-04 01:22
Lumos Receives US FDA Clearance for FebriDx® 2023-07-03 21:50
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023 2023-07-03 18:59
Henlius Forecasts Profit in 1H 2023 2023-07-03 17:49
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma 2023-07-03 08:00
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease 2023-07-03 08:00
Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing 2023-07-02 14:00
Transcenta Presented PFS Data by CLDN18.2 Expression Level from Phase I/II Study of Osemitamab (TST001) plus CAPOX as the First-Line Treatment of Advanced G/GEJ Cancer at ESMO GI Annual Congress 2023 2023-06-30 17:33
BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification 2023-06-30 08:37
Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology 2023-06-29 20:00
1 95 96 97 98 99 452